A Clinical Study Comparing SG301 Plus Pomalidomide and Dexamethasone to Placebo Plus Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Patients

Clinical trial NCT06508983 · RECRUITING

Trial details

NCT number: NCT06508983
Sponsor: Hangzhou Sumgen Biotech Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsed/Refractory Multiple Myeloma

Start date: 2024-06-14
Primary completion: 2027-03-31
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.